Cargando…
Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis
For patients with lupus erythematosus (LE) or dermatomyositis (DM), there is an urgent need to address a heightened risk of clinical events, chiefly heart attacks and strokes, caused by atherosclerotic cardiovascular disease (ASCVD). Patients with LE or DM frequently exhibit high levels of conventio...
Autores principales: | Keyes, Emily, Grinnell, Madison, Jacoby, Douglas, Vazquez, Thomas, Diaz, DeAnna, Werth, Victoria P., Williams, Kevin Jon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721062/ https://www.ncbi.nlm.nih.gov/pubmed/35024413 http://dx.doi.org/10.1016/j.ijwd.2021.08.015 |
Ejemplares similares
-
State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus
por: Zhao, Megan, et al.
Publicado: (2023) -
Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series
por: Keyes, Emily, et al.
Publicado: (2021) -
Erythromelalgia associated with dermatomyositis: A case series
por: Grinnell, Madison, et al.
Publicado: (2021) -
Dermatomyositis associated with hyponatremia and anasarca
por: Grinnell, Madison, et al.
Publicado: (2021) -
Herbal supplement Spirulina stimulates inflammatory cytokine production in patients with dermatomyositis in vitro
por: Bax, Christina E., et al.
Publicado: (2023)